These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1781034)
1. Sex comparison of heme pathway in rats bearing hepatic tumors. Wainstok de Calmanovici R; Cochón AC; Aldonatti C; Cabral JR; San Martín de Viale LC Tumori; 1991 Oct; 77(5):379-84. PubMed ID: 1781034 [TBL] [Abstract][Full Text] [Related]
2. Influence of hepatic tumors caused by diethylnitrosamine on hexachlorobenzene-induced porphyria in rats. Wainstok de Calmanovici R; Cochón AC; Zenklusen JC; Aldonatti C; Cabral JR; San Martín de Viale LC Cancer Lett; 1991 Jul; 58(3):225-32. PubMed ID: 1649694 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of hexachlorobenzene-induced porphyria in rats. Effect of phenobarbitone pretreatment. Wainstok de Calmanovici R; Ríos de Molina MC; Taira de Yamasato MC; Tomio JM; San Martin de Viale LC Biochem J; 1984 Mar; 218(3):753-63. PubMed ID: 6721832 [TBL] [Abstract][Full Text] [Related]
4. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of mammary tumors on hexachlorobenzene-induced porphyria in rats. Wainstok de Calmanovici R; Cochón AC; Aldonatti C; Bergoc R; San Martín de Viala LC Cancer Lett; 1990 Nov; 55(1):67-73. PubMed ID: 2245412 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene]. Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026 [TBL] [Abstract][Full Text] [Related]
7. Enzyme abnormalities in the porphyrias. Brodie MJ; Moore MR; Goldberg A Lancet; 1977 Oct; 2(8040):699-701. PubMed ID: 71507 [TBL] [Abstract][Full Text] [Related]
8. Liver ferrochelatase from normal and hexachlorobenzene porphyric rats. Mechanism of drug action. Ríos de Molina MC; Billi de Catabbi S; San Martín de Viale LC Int J Biochem; 1991; 23(7-8):669-73. PubMed ID: 1864443 [TBL] [Abstract][Full Text] [Related]
9. Liver ferrochelatase from normal and hexachlorobenzene porphyric rats. Studies on their properties. Rios de Molina MC; Taira MC; San Martin de Viale LC Int J Biochem; 1989; 21(2):219-25. PubMed ID: 2744203 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of porphyrinogenic effect of lindane in rats]. Vila MC; Aldonatti C; San Martín de Viale LC Acta Physiol Pharmacol Latinoam; 1986; 36(1):69-76. PubMed ID: 2429498 [TBL] [Abstract][Full Text] [Related]
11. Influence of the strain of rats on the induction of hexachlorobenzene induced porphyria. Wainstok de Calmanovici R; Billi de Catabbi SC; Aldonatti CA; San Martín de Viale LC Int J Biochem; 1989; 21(4):377-81. PubMed ID: 2744208 [TBL] [Abstract][Full Text] [Related]
12. The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage. Ríos de Molina MC; Mazzetti MB; Galigniana M; Aldonatti C; Tomio JM; San Martín de Viale LC Braz J Med Biol Res; 2002 Nov; 35(11):1273-83. PubMed ID: 12426626 [TBL] [Abstract][Full Text] [Related]
13. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence. De Catabbi SCB ; Aldonatti C; de Viale LC Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027 [TBL] [Abstract][Full Text] [Related]
14. Alterations of heme, cytochrome P-450, and steroid metabolism by mercury in rat adrenal. Veltman JC; Maines MD Arch Biochem Biophys; 1986 Aug; 248(2):467-78. PubMed ID: 2943220 [TBL] [Abstract][Full Text] [Related]
16. Influence of N-acetylcysteine on the hexachlorobenzene induced porphyria in rats. Lissner R; Brunner W; Bolsen K; Merk H; Goerz G Arzneimittelforschung; 1985; 35(4):713-5. PubMed ID: 4015737 [TBL] [Abstract][Full Text] [Related]
17. Hexachlorobenzene as a promoter of diethylnitrosamine-initiated hepatocarcinogenesis in rats and comparison with induction of porphyria. Stewart FP; Manson MM; Cabral JR; Smith AG Carcinogenesis; 1989 Jul; 10(7):1225-30. PubMed ID: 2736716 [TBL] [Abstract][Full Text] [Related]
18. Relationships between acute hepatic porphyrias due to genetic variability of primary enzyme defects and limiting function of uroporphyrinogen synthase. Doss M Int J Biochem; 1978; 9(12):911-6. PubMed ID: 744295 [No Abstract] [Full Text] [Related]
19. Effect of an iron chelator on the onset of hexachlorobenzene-induced porphyria in rats. Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC IARC Sci Publ; 1986; (77):507-11. PubMed ID: 3596749 [TBL] [Abstract][Full Text] [Related]
20. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria. Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]